Bavarian Nordic A/S (BVNRY)
OTHER OTC:BVNRY

Bavarian Nordic Stock Analysis & Ratings

BVNRY Stock Chart & Stats

Day’s Range$10.25 - $11.7
52-Week Range$5.85 - $19.25
Previous Close$10.83
Volume473.65K
Average Volume (3M)6.95K
Market Cap$2.37B
P/E Ratio-21.8
Beta1.40
Next EarningsAug 24, 2022
EPS ForecastN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score2
EPS (TTM)-0.47


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

BVNRY FAQ

What was Bavarian Nordic’s price range in the past 12 months?
Bavarian Nordic lowest stock price was $5.85 and its highest was $19.25 in the past 12 months.
    What is Bavarian Nordic’s market cap?
    Bavarian Nordic’s market cap is $2.37B.
      What is Bavarian Nordic’s price target?
      Currently, no data Available
      What do analysts say about Bavarian Nordic?
      Not enough analysts have published a price target to provide an average price target.
      When is Bavarian Nordic’s upcoming earnings report date?
      Bavarian Nordic’s upcoming earnings report date is Aug 24, 2022 which is in 93 days.
        How were Bavarian Nordic’s earnings last quarter?
        Bavarian Nordic released its earnings results on May 09, 2022. The company reported -$0.194 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.194.
          Is Bavarian Nordic overvalued?
          According to Wall Street analysts Bavarian Nordic’s price is currently Overvalued.
            Does Bavarian Nordic pay dividends?
            Bavarian Nordic pays a Notavailable dividend of $0.42 which represents an annual dividend yield of N/A. Bavarian Nordic’s last Notavailable dividend payment was on Apr 06, 2020. Bavarian Nordic’s upcoming ex-dividend date is Mar 27, 2020
              What is Bavarian Nordic’s EPS estimate?
              Bavarian Nordic’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Bavarian Nordic have?
              Bavarian Nordic has 210,980,000 shares outstanding.
                What happened to Bavarian Nordic’s price movement after its last earnings report?
                Bavarian Nordic reported an EPS of -$0.194 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.333%.
                  Which hedge fund is a major shareholder of Bavarian Nordic?
                  Currently, no hedge funds are holding shares in BVNRY

                  ---

                  Bavarian Nordic Stock Analysis

                  Smart Score
                  2
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  Price Target
                  No data currently available
                  The Bavarian Nordic stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Bavarian Nordic A/S

                  Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Johnson & Johnson
                  Novavax
                  Vaxart
                  Lumos Pharma
                  Inovio Pharmaceuticals

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis